Intermittent catheterisation (IC) is a commonly recommended procedure for people with incomplete bladder emptying. Frequent complications are urinary tract infection (UTI), urethral trauma and discomfort during catheter use.
Urinary catheters (UC) are used by some surgeons during total joint arthroplasty (TJA). This study investigated the impact of intraoperative urinary catheters on postoperative urinary retention (POUR) following TJA cases.
We aimed to characterize the urinary microbiome of catheterizing patients with neurogenic lower urinary tract dysfunction (NLUTD) and to evaluate differences based on type of bladder management or frequency of urinary tract infections.
Holmium laser enucleation of prostate (HoLEP) represents one of the most studied surgical techniques for benign prostatic hyperplasia (BPH). Its efficacy in symptom relief has been widely depicted. However, few evidence is available regarding the possible predictors of symptom recurrence.
(UroToday.com) In a session at the American Society for Radiation Oncology (ASTRO) Annual Congress focused on the care of patients with intermediate and high-risk prostate cancer, Dr. Kwok presented results of a prospective trial of aggressive therapy consisting of neoadjuvant chemotherapy and androgen deprivation therapy (ADT) followed by prostatectomy and adjuvant radiotherapy for patients with high […]
(UroToday.com) In a session at the American Society for Radiation Oncology (ASTRO) Annual Congress focused on the care of patients with intermediate and high-risk prostate cancer, Dr. Romero presented on the relationship between androgen deprivation therapy (ADT) duration and external beam radiotherapy (EBRT) with or without brachytherapy boost in high-risk prostate cancer.
(UroToday.com) In an educational session at the American Society for Radiation Oncology (ASTRO) Annual Congress focused on the best treatment for early prostate cancer, Dr. Morton presented on advances in prostate brachytherapy.
(UroToday.com) In a GU session at the American Society for Radiation Oncology (ASTRO) Annual Congress, Dr. Glicksman presented pooled results from four prospective trials evaluating the role of elective nodal ultra hypofractionated radiation in treatment of patients with prostate cancer.
(UroToday.com) In a special session of the American Society for Radiation Oncology (ASTRO) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) held at the 2021 ASTRO Annual Congress, Dr. Parent presented on the role of molecular imaging and targeted radionuclide therapy using PSMA-based radiopharmaceuticals.
(UroToday.com) In a GU session at the American Society for Radiation Oncology (ASTRO) Annual Congress, Dr. Yamoah presented work defining racial disparities across the spectrum of prostate cancer in an equal access to care setting. Dr. Yamoah began by emphasizing that racial disparities in prostate cancer are multi-dimensional and likely span the entirety of the disease […]
